Extensive biliary excretion of the model opioid peptide [D.PEN2,5]] enkephalin in rats

Pharmaceutical Research

Volumn 14, Issue 3, 1997, Pages 345-350

  Chen, Cuiping ^a   Pollack, Gary M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Biliary excretion; CZE; DPDPE; Opioid peptide

Indexed keywords

ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; OPIATE PEPTIDE;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; CAPILLARY ZONE ELECTROPHORESIS; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG PROTEIN BINDING; DRUG URINE LEVEL; ERYTHROCYTE; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION;

ANALGESICS; ANIMALS; BILE; ELECTROPHORESIS, CAPILLARY; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; LIVER; MALE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0030933482     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012054222845     Document Type: Article

References (20)

1. W. A. Banks. Proc. Natl. Acad. Sci. U.S.A. 87:6762-6766 (1990).
2. W. Bouer, W. Briner, W. Doepfner, R. Haller, R. Huguenin, P. Marbach, T. J. Petcher, and J. Pless. Life Sci. 31:1133-1140 (1982).
3. B. D. Khan, C. T. Van Buren, S. M. Flechner, W. D. Payne, M. Boileau, and R. H. Kerman. Transplant. Proc. 15:2469-2487 (1983).
4. C. E. Peters. Reg. Pept. 3:361-369 (1982).
5. M. Sheppard, B. Shapiro, B. Pimstone, S. Kronheim, B. Berelowite, and M. Gregory. J. Clin. Endocrinol. Metab. 48:50-53 (1979).
6. S. Muller and G. Hochhaus. Pharm. Res. 12:1165-1170 (1995).
7. R. Albert, P. Marbach, W. Bauer, U. Briner, G. Fricker, and J. Pless. Life Sci. 25:517-525 (1993).
8. J. C. Greenfield, K. J. Cook, and I. A. Oleary. Drug Metab. Dispos. 17:518-525 (1989).
9. K. Ziegler, M. Primmer, H. Kessler, I. Damm, V. Eiermann, S. Roll, and J. Zarbock. Biochim. Biophys. Acta 845:86-93 (1985).
10. K. Ziegler, W. Lins, and M. Frimmer. Biochim. Biophys. Acta 1061:287-296 (1991).
11. H. I. Mosberg, R. Hurst, V. J. Hruby, K. Gee, H. I. Yamamura, J. J. Galligan, and T. F. Burks. Proc. Natl. Acad. Sci. U.S.A. 80:5871-5874 (1983).
12. S. J. Weber, D. L. Greene, S. D. Sharma, H. I. Yamamura, T. H. Kramer, T. F. Burks, V. J. Hruby, L. B. Hersh, and T. P. Davis. J. Pharmacol. Exp. Ther. 259:1109-1117 (1991).
13. S. J. Weber, D. L. Greene, V. J. Hruby, H. I. Yamamura, F. Porreca, and T. P. Davis. J. Pharmacol. Exp. Ther. 263:1308-1316 (1992).
14. L. B. Hersh. J. Neurochem. 43:487-493 (1984).
15. C. Chen and G. M. Pollack. J. Chromatogr. B 681:363-373 (1996).
16. D. M. C. Ouellet and G. M. Pollack. Drug Metab. Dispos. 23:478-484 (1995).
17. M. Lemaire, M. Azria, R. Dannecker, P. Marbach, A. Schweitzer, and G. Maurer. Drug Metab. Dispos. 17:699-703 (1989).
18. T. Terasaki, H. Mizuguchi, C. Itoho, I. Tamai, M. Lemaire, and A. Tsuji. Pharm. Res. 12:12-17 (1995).
19. T. Nakamura, A. Hisaka, Y. Sawasaki, Y. Suzuki, T. Fukami, K. Ishikawa, M. Yano and Y. Sugiyama. J. Pharmacol. Exp. Ther. 278:564-278 (1996).
20. A. Lindholm. Ther. Drug Monit. 13:465-477 (1991).